Jump Financial’s Syndax Pharmaceuticals SNDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.57M | Buy |
+381,035
| New | +$3.57M | 0.04% | 515 |
|
|
2025
Q1 | – | Sell |
-173,890
| Closed | -$2.3M | – | 1982 |
|
|
2024
Q4 | $2.3M | Buy |
173,890
+77,699
| +81% | +$1.03M | 0.05% | 463 |
|
|
2024
Q3 | $1.85M | Buy |
96,191
+58,691
| +157% | +$1.13M | 0.04% | 549 |
|
|
2024
Q2 | $770K | Buy |
+37,500
| New | +$770K | 0.02% | 939 |
|
|
2023
Q4 | – | Sell |
-154,786
| Closed | -$2.25M | – | 2201 |
|
|
2023
Q3 | $2.25M | Buy |
154,786
+118,500
| +327% | +$1.72M | 0.08% | 321 |
|
|
2023
Q2 | $759K | Buy |
+36,286
| New | +$759K | 0.03% | 825 |
|
|
2022
Q2 | – | Sell |
-41,800
| Closed | -$726K | – | 1994 |
|
|
2022
Q1 | $726K | Sell |
41,800
-13,813
| -25% | -$240K | 0.03% | 655 |
|
|
2021
Q4 | $1.22M | Buy |
+55,613
| New | +$1.22M | 0.08% | 332 |
|
|
2021
Q1 | – | Sell |
-16,011
| Closed | -$356K | – | 1256 |
|
|
2020
Q4 | $356K | Buy |
+16,011
| New | +$356K | 0.06% | 527 |
|